Navigation Links
Nanobiotix and BiotechCorp Announce Initial Focus of Their Collaboration: P-O-C Diagnostics and Drug Delivery Systems for Tropical Diseases, Such as Malaria
Date:9/24/2008

Nanobiotix, an emerging nanomedicine company focused on cancer therapy, announced today that the Company and its partner, Malaysian Biotechnology Corporation Sdn Bhd (BiotechCorp), will initially focus their collaboration on developing point-of-care (P-O-C) diagnostics and drug delivery systems for tropical diseases, such as malaria. BiotechCorp has acquired an exclusive, global license to a Nanobiotix nanotechnology platform for non-cancer purposes. As part of the collaboration, three BiotechCorp scientists will take up residence at Nanobiotix for a period of 12 months to undergo the technology transfer training.

PARIS (Business Wire EON) September 24, 2008 -- Malaria is a disease that can be transmitted to people of all ages through the bites of infected mosquitoes. Approximately 40% of the world's population is at risk of malaria. Every year, more than 500 million people worldwide become severely ill with malaria. Early diagnosis and effective treatment of malaria disease will shorten its duration and prevent the development of complications and the great majority of deaths from malaria.

"We are proud to be the first partner of Nanobiotix outside of its cancer focus," said BiotechCorp's CEO Datuk Iskandar Mizal Mahmood. "We firmly believe that the opportunity to help save millions of lives is in fact a near-term possibility as a result of this collaboration between BiotechCorp and Nanobiotix. Additionally, this collaboration is a significant testimony to the readiness of the Malaysian biotechnology industry in commercializing science to market, whilst addressing challenges in our part of the world."

"BiotechCorp offers Nanobiotix a direct route through Asia," said Laurent Lvy, Ph.D., President and CEO of Nanobiotix and Co-President of the French Technology Platform on Nanomedicine (FTPN). "Certainly, their strategic location in th
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Swiss Institute of Bioinformatics announces major breakthrough
2. VA Announces Changes to the Disability Rating Schedule for Traumatic Brain Injuries and Burn Scars
3. VA Announces $36 Million in Grants for Homeless Programs
4. The Lanier Law Firm Announces Wrongful Death Lawsuit Against Rice University, Former Coach, NCAA, Others in Students Sickle-Cell Death
5. Hissey Kientz, LLP Announces the Launch of Digitek Recall Help Web Site
6. LifeMasters Announces Agreement to Offer Disease Management Services to High-Risk Wisconsin Residents
7. Hanger Orthopedic Group, Inc. Announces Underwritten Public Offering by Shareholder
8. Satellite Healthcare Announces 2008 Norman S. Coplon Extramural Grants : Grants Foster Next-Generation Kidney Disease Researchers
9. Natural Alternatives International, Inc. Announces Fiscal 2008 Results
10. Arrowsight Announces Appointment of Suzanne Delbanco as President of Health Care Division
11. Radiation Oncology Services of America, Inc. Announces Formation of Scientific Advisory Board

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...rchers from the California Institute of Technology...or the first time, the previously mysterious proce...tin are added by enzymes called ubiquitin ligases ... chains tag target proteins for destruction by pro...d that ubiquitin ligases build ubiquitin chains ve...
(Date:12/2/2009)...int-induced movement therapy (CIMT) is a potential...h hemiplegic cerebral palsy, but more research is ...shed in the November issue of Physical Therapy (...cal Therapy Association (APTA). The review, which ...reviews, concluded that further research should fo...
(Date:12/2/2009)... National Race Series to increase awareness of pro... the importance of early detection , ... Men, women, families, friends and neighbors &ndas...rticipate in the Rudolph Ramble 5K. The Rudolph R...es , which was launched by the Prostate Condition...
(Date:12/2/2009).... 2 In response to rising suicide ...Life, a non-profit ministry dedicated to supportin...d to Remember® marriage conference at a sign...om Dec. 11 - 13 at the Grand Hyatt Atlanta in Buck...er is a marriage getaway aimed at strengthening h...
(Date:12/2/2009)...ES, Dec. 2 At a recentl... ministerial delegates came together to outline th... to give it the necessary thrust. Organized by the...ourismassociation.com , the high-powered congregat...d the opportunities and requests for assistance in...
Breaking Medicine News(10 mins):Health News:Caltech scientists show how ubiquitin chains are added to cell-cycle proteins 2Health News:Caltech scientists show how ubiquitin chains are added to cell-cycle proteins 3Health News:Caltech scientists show how ubiquitin chains are added to cell-cycle proteins 4Health News:Report shows CIMT may improve arm use in children with hemiplegic cerebral palsy 2Health News:PACE Race Returns with Denver's Rudolph Ramble 2Health News:PACE Race Returns with Denver's Rudolph Ramble 3Health News:PACE Race Returns with Denver's Rudolph Ramble 4Health News:FamilyLife Supports Military Marriages in Atlanta 2Health News:Ministerial Roundtable Discusses Future of Medical Tourism 2Health News:Ministerial Roundtable Discusses Future of Medical Tourism 3
...lif., July 10 Nationwide,Health Properties, Inc. ...oined NHP as its Vice President, Tax. Mr. Laty had...roy Realty Corporation since 2001. He also had,ove...raduate of California State University, Fullerton ...
...al microscope with a tip the size of a needle, Sta...ers of working muscles in live humans, with minimu...are sure to welcome. , This microendoscopy techni...uscle biopsy in which a portion of the muscle is r...
...10 Two leading U.S. House,Judiciary Committee mem...use Judiciary Committee and Rep. Lamar Smith, rank...sked U.S. Attorney General Michael B. Mukasey to,h... copper miner ASARCO., In a letter to Attorney Ge...
...ch. A new University of Michigan study in mice sug...r tumors is also able to reduce the effects of gra...al complication for people who have had bone marro...s expect to begin a trial within a year. , The U...
...r Stroll, Four ways to get to the finish line. T...ly 10 5k Your Way, a fundraiser,benefitting Coura...Courage,Center in Golden Valley. In addition to a ...d information about Courage,Center programs and se...
...e beneficial for men is not good for women, study ...) -- Whether drinking alcohol helps or hurts your ...epend on your gender as well as how much you imbib...,000 Japanese men and women over a 14-year period....
Other Medicine News:Health News:Stanford Bio-X researchers use needle-thin probe to get first look at working muscle fiber 2Health News:Chair, Ranking Member of U.S. House Judiciary Committee Urge DOJ to do 'Careful Study' of Environmental Record of Vedanta/Sterlite, Other Would-Be Buyers of ASARCO 2Health News:Chair, Ranking Member of U.S. House Judiciary Committee Urge DOJ to do 'Careful Study' of Environmental Record of Vedanta/Sterlite, Other Would-Be Buyers of ASARCO 3Health News:Cancer drug shows promise against graft vs. host disease 2Health News:Cancer drug shows promise against graft vs. host disease 3Health News:Teams Forming for Courage Center 5k Your Way 2Health News:Alcohol's Impact on Heart, Stroke Risk Differs by Gender 2
(Date:12/2/2009)..., LUND, Sweden, December 2 Der...atology and wound healing company "Pergamum" -,tod...ng results from a,clinical Phase I/IIa study. Derm...e (AMP) treatment for atopic dermatitis. Atopic de...ere dry skin and the skin,s weakened barrier,funct...
(Date:12/2/2009)...HAIFA, Isreal, December 2 /PRNewswire-FirstCall/ -...a leading developer of advanced,cardiovascular sur...s Board,of Directors approved a one-for-three forw...payable to Cardio Vascular Medical Device sharehol...course the estimated date the stock,split will be ...
(Date:12/2/2009)...M, Ala., Dec. 2 Adults are more ... cancer. For adults 65 and over, the odds of losin...an developing prostate cancer are one in six and o... nine. Vision loss threatens the overall health o... depression and inability to complete daily tasks....
Breaking Medicine Technology:Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 2Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 3Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 4Cardio Vascular Medical Device Announces Forward Stock Split 2Risk of Vision Loss in Aging Adults is Greater Than Risk of Breast or Prostate Cancer 2Smallpox the death of a disease 49517 1Smallpox the death of a disease 49517 2Urologist and Allergist Explore Link Between Allergies and Interstitial Cystitis 4620 1Urologist and Allergist Explore Link Between Allergies and Interstitial Cystitis 4620 2Urologist and Allergist Explore Link Between Allergies and Interstitial Cystitis 4620 3Urologist and Allergist Explore Link Between Allergies and Interstitial Cystitis 4620 4Study of agricultural watersheds and carbon losses 8933 1Study of agricultural watersheds and carbon losses 8933 2
...ugh,Corporation (NYSE: SGP ) announced today that...esentations from about 60 clinical studies relatin...ted at the upcoming 44th,Annual Meeting of the Ame...go, May 30 - June 3. Data will be presented on TEM...ted liposomal doxorubicin,hydrochloride), INTRON(R...
...resented at the National Lipid Asso... N.J., May 30 Daiichi Sankyo, Inc.,announced toda...l studies,demonstrated that the addition of Welcho...ent regimens can lower A1C in patients with type 2...included all patients receiving,Welchol in these s...
Other Medicine Technology:About 60 Clinical Studies Regarding Schering-Plough's Oncology Compounds Will be Presented at ASCO 2Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 2Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 3Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 4Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 5Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 6
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
Medicine Products: